共 50 条
Application of the SCAI classification in a cohort of patients with cardiogenic shock
被引:132
|作者:
Schrage, Benedikt
[1
,2
]
Dabboura, Salim
[1
]
Yan, Isabell
[1
]
Hilal, Rafel
[1
]
Neumann, Johannes T.
[1
,2
]
Sorensen, Nils A.
[1
,2
]
Gossling, Alina
[1
]
Becher, Peter Moritz
[1
]
Grahn, Hanno
[1
]
Wagner, Tobias
[1
]
Seiffert, Moritz
[1
]
Kluge, Stefan
[3
]
Reichenspurner, Hermann
[4
]
Blankenberg, Stefan
[1
,2
]
Westermann, Dirk
[1
,2
]
机构:
[1] Univ Heart Ctr Hamburg, Dept Intervent & Gen Cardiol, Hamburg, Germany
[2] Partner Site Hamburg Lubeck Kiel, German Ctr Cardiovasc Res DZHK, Hamburg, Germany
[3] Univ Clin Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany
[4] Univ Heart Ctr Hamburg, Dept Cardiothorac Surg, Hamburg, Germany
关键词:
cardiogenic shock;
classification;
SCAI;
MECHANICAL CIRCULATORY SUPPORT;
MYOCARDIAL-INFARCTION;
SURVIVAL;
D O I:
10.1002/ccd.28707
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background The Society of Cardiovascular Angiography and Interventions (SCAI) have recently proposed a new classification of cardiogenic shock (CS) dividing patients into five subgroups. Objective Aim of this study was to apply the SCAI classification to a cohort of patients presenting with CS and to evaluate its ability to predict 30-day survival. Methods SCAI CS subgroups were interpreted based on the recent consensus statement and then applied to N = 1,007 consecutive patients presenting with CS or large myocardial infarction (MI) between October 2009 and October 2017. The association between SCAI classification and 30-day all-cause mortality was assessed by logistic regression analysis. Results Mean age in the study cohort was 67 (+/- 15) years, 72% were male. Mean lactate at baseline was 6.05 (+/- 5.13) mmol/l and 51% of the patients had prior cardiac arrest. Overall survival probability was 50.6% (95% confidence interval [CI] 47.5-54.0%). In view of the SCAI classification, the survival probability was 96.4% (95% CI 93.7-99.0%) in class A, 66.1% (95% CI 50.2-87.1%) in class B, 46.1% (95% CI 40.6-52.4%) in class C, 33.1% (95% CI 26.6-41.1%) in class D, and 22.6% (95% CI 17.1-30.0%) in class E. Higher SCAI classification was significantly associated with lower 30-day survival (p < .01). Conclusion In this large clinical cohort, the SCAI classification was significantly associated with 30-day survival. This finding supports the rationale of the SCAI CS classification and calls for a validation in a prospective trial.
引用
收藏
页码:E213 / E219
页数:7
相关论文